Metabolic acidosis and the progression of chronic kidney disease

BMC Nephrology

Volumn 15, Issue 1, 2014, Pages

  Chen, Wei ^a   Abramowitz, Matthew K ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Aldosterone; Alkali; Ammonia; Bicarbonate; Complement; Dietary acid; Endothelin; Net endogenous acid production; Sodium bicarbonate

Indexed keywords

ALKALI; BICARBONATE; CITRATE SODIUM; CITRIC ACID;

BICARBONATE BLOOD LEVEL; CHRONIC KIDNEY DISEASE; DIET; DISEASE COURSE; END STAGE RENAL DISEASE; HUMAN; METABOLIC ACIDOSIS; OUTCOME ASSESSMENT; REVIEW; ACIDOSIS; COMPLICATION; DIET THERAPY; PROCEDURES; RENAL INSUFFICIENCY, CHRONIC; RISK FACTOR; SURVIVAL RATE; TREATMENT OUTCOME;

ACIDOSIS; CITRATES; DIET THERAPY; DISEASE PROGRESSION; HUMANS; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; SODIUM BICARBONATE; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84898544862     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-15-55     Document Type: Review

References (71)

1. Prevalence of chronic kidney disease in the United States. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS, JAMA 2007 298 17 2038 2047 10.1001/jama.298.17.2038 17986697 (Pubitemid 350074801)
2. Timing of onset of CKD-related metabolic complications. Moranne O, Froissart M, Rossert J, Gauci C, Boffa JJ, Haymann JP, M'Rad MB, Jacquot C, Houillier P, Stengel B, Fouqueray B, the NephroTest Study Group, J Am Soc Nephrol 2009 20 1 164 171 10.1681/ASN.2008020159 19005010
3. Prevalence of acidosis and inflammation and their association with low serum albumin in chronic kidney disease. Eustace JA, Astor B, Muntner PM, Ikizler TA, Coresh J, Kidney Int 2004 65 3 1031 1040 10.1111/j.1523-1755.2004. 00481.x 14871424 (Pubitemid 38251079)
4. Serum bicarbonate levels and the progression of kidney disease: a cohort study. Shah SN, Abramowitz M, Hostetter TH, Melamed ML, Am J Kidney Dis 2009 54 2 270 277 10.1053/j.ajkd.2009.02.014 19394734
5. The effects of metabolic acidosis on bone formation and bone resorption in the rat. Kraut JA, Mishler DR, Singer FR, Goodman WG, Kidney Int 1986 30 5 694 700 10.1038/ki.1986.242 3784302 (Pubitemid 17049587)
6. Effect of metabolic acidosis on insulin action and secretion in uremia. Mak RH, Kidney Int 1998 54 2 603 607 10.1046/j.1523-1755.1998.00023.x 9690228 (Pubitemid 28357424)
7. The acidosis of chronic renal failure activates muscle proteolysis in rats by augmenting transcription of genes encoding proteins of the ATP-dependent ubiquitin-proteasome pathway. Bailey JL, Wang X, England BK, Price SR, Ding X, Mitch WE, J Clin Invest 1996 97 6 1447 1453 10.1172/JCI118566 8617877 (Pubitemid 26097034)
8. Impaired actions of insulin-like growth factor 1 on protein Synthesis and degradation in skeletal muscle of rats with chronic renal failure. Evidence for a postreceptor defect. Ding H, Gao XL, Hirschberg R, Vadgama JV, Kopple JD, J Clin Invest 1996 97 4 1064 1075 10.1172/JCI118499 8613530 (Pubitemid 26074153)
9. Chronic metabolic acidosis decreases albumin synthesis and induces negative nitrogen balance in humans. Ballmer PE, McNurlan MA, Hulter HN, Anderson SE, Garlick PJ, Krapf R, J Clin Invest 1995 95 1 39 45 10.1172/JCI117668 7814640
10. Association of serum bicarbonate levels with mortality in patients with non-dialysis-dependent CKD. Kovesdy CP, Anderson JE, Kalantar-Zadeh K, Nephrol Dial Transplant 2009 24 4 1232 1237 19015169
11. Higher serum bicarbonate levels within the normal range are associated with better survival and renal outcomes in African Americans. Raphael KL, Wei G, Baird BC, Greene T, Beddhu S, Kidney Int 2011 79 3 356 362 10.1038/ki.2010.388 20962743
12. Serum bicarbonate and long-term outcomes in CKD. Menon V, Tighiouart H, Vaughn NS, Beck GJ, Kusek JW, Collins AJ, Greene T, Sarnak MJ, Am J Kidney Dis 2010 56 5 907 914 10.1053/j.ajkd.2010.03.023 20605301
13. Serum bicarbonate and mortality in stage 3 and stage 4 chronic kidney disease. Navaneethan SD, Schold JD, Arrigain S, Jolly SE, Wehbe E, Raina R, Simon JF, Srinivas TR, Jain A, Schreiber MJ Jr, Nally JV Jr, Clin J Am Soc Nephrol 2011 6 10 2395 2402 10.2215/CJN.03730411 21885787
14. Association of serum bicarbonate with risk of renal and cardiovascular outcomes in CKD: a report from the Chronic Renal Insufficiency Cohort (CRIC) study. Dobre M, Yang W, Chen J, Drawz P, Hamm LL, Horwitz E, Hostetter T, Jaar B, Lora CM, Nessel L, Ojo A, Scialla J, Steigerwalt S, Teal V, Wolf M, Rahman M, Am J Kidney Dis 2013 62 4 670 678 10.1053/j.ajkd.2013.01.017 23489677
15. High serum bicarbonate level within the normal range prevents the progression of chronic kidney disease in elderly chronic kidney disease patients. Kanda E, Ai M, Yoshida M, Kuriyama R, Shiigai T, BMC Nephrol 2013 14 4 10.1186/1471-2369-14-4 23298330
16. Serum bicarbonate and mortality in adults in NHANES III. Raphael KL, Zhang Y, Wei G, Greene T, Cheung AK, Beddhu S, El Nahas M, Nephrol Dial Transplant 2013 28 5 1207 1213 10.1093/ndt/gfs609 23348878
17. Rose BD, Post TW, Clinical Physiology of Acid-base and Electrolyte Disorders USA: McGraw-Hill Fifth 2000
18. The Excretion of Ammonia and Titratable Acid in Nephritis. Van Slyke DD, Linder GC, Hiller A, Leiter L, McIntosh JF, J Clin Invest 1926 2 3 255 288 10.1172/JCI100045 16693681
19. On the mechanism of acidosis in chronic renal disease. Schwartz WB, Hall PW 3rd, Hays RM, Relman AS, J Clin Invest 1959 38 1, Part 1 39 52 13620770
20. Renal Acidosis and Renal Excretion of Acid in Health and Disease. Relman AS, Adv Intern Med 1964 12 295 347 14268281
21. Production, Excretion, and Net Balance of Fixed Acid in Patients with Renal Acidosis. Goodman AD, Lemann J Jr, Lennon EJ, Relman AS, J Clin Invest 1965 44 495 506 10.1172/JCI105163 14278166
22. The effect of treatment of acidosis on calcium balance in patients with chronic azotemic renal disease. Litzow JR, Lemann J Jr, Lennon EJ, J Clin Invest 1967 46 2 280 286 10.1172/JCI105530 6018764
23. A re-evaluation of the urinary parameters of acid production and excretion in patients with chronic renal acidosis. Uribarri J, Douyon H, Oh MS, Kidney Int 1995 47 2 624 627 10.1038/ki.1995.79 7723250
24. Metabolic acidosis in chronic renal insufficiency. Gennari FJ, Acid-base disorders and their treatment Boca Raton: Taylor & Francis, Gennari FJ, Adrogue HJ, Galla JH, Madias NE, 2005 469 485
25. Biochemical parameters in chronic renal failure. Hakim RM, Lazarus JM, Am J Kidney Dis 1988 11 3 238 247 3125741 (Pubitemid 18086765)
26. Serum electrolyte patterns in end-stage renal disease. Wallia R, Greenberg A, Piraino B, Mitro R, Puschett JB, Am J Kidney Dis 1986 8 2 98 104 3090875 (Pubitemid 17170265)
27. Serum electrolyte and acid base composition. The influence of graded degrees of chronic renal failure. Widmer B, Gerhardt RE, Harrington JT, Cohen JJ, Arch Intern Med 1979 139 10 1099 1102 10.1001/archinte.1979.03630470021010 485740 (Pubitemid 10115917)
28. The serum anion gap is altered in early kidney disease and associates with mortality. Abramowitz MK, Hostetter TH, Melamed ML, Kidney Int 2012 82 6 701 709 10.1038/ki.2012.196 22622500
29. Control of hydrogen ion homeostasis and renal acidosis. Simpson DP, Medicine 1971 50 6 503 541 10.1097/00005792-197111000-00002 4942419
30. Ammonium excretion in chronic metabolic acidosis: benefits and risks. Halperin ML, Ethier JH, Kamel KS, Am J Kidney Dis 1989 14 4 267 271 2679056 (Pubitemid 19254011)
31. Pathophysiology of chronic tubulo-interstitial disease in rats. Interactions of dietary acid load, ammonia, and complement component C3. Nath KA, Hostetter MK, Hostetter TH, J Clin Invest 1985 76 2 667 675 10.1172/JCI112020 2993363 (Pubitemid 15023121)
32. Physiology of endothelin and the kidney. Kohan DE, Inscho EW, Wesson D, Pollock DM, Compr Physiol 2011 1 2 883 919 23737206
33. Involvement of angiotensin II and endothelin in matrix protein production and renal sclerosis. Ruiz-Ortega M, Gomez-Garre D, Alcazar R, Palacios I, Bustos C, Gonzalez S, Plaza JJ, Gonzalez E, Egido J, J Hypertens Suppl 1994 12 4 51 58 7965275
34. Role of endothelin in the development of glomerulosclerosis. Remuzzi G, Kidney Blood Press Res 1996 19 3-4 182 183 8887257 (Pubitemid 26379987)
35. Endogenous endothelins mediate increased distal tubule acidification induced by dietary acid in rats. Wesson DE, J Clin Invest 1997 99 9 2203 2211 10.1172/JCI119393 9151792 (Pubitemid 27203776)
36. Dietary protein induces endothelin-mediated kidney injury through enhanced intrinsic acid production. Wesson DE, Nathan T, Rose T, Simoni J, Tran RM, Kidney Int 2007 71 3 210 217 10.1038/sj.ki.5002036 17164833 (Pubitemid 46160921)
37. Dietary protein causes a decline in the glomerular filtration rate of the remnant kidney mediated by metabolic acidosis and endothelin receptors. Phisitkul S, Hacker C, Simoni J, Tran RM, Wesson DE, Kidney Int 2008 73 2 192 199 10.1038/sj.ki.5002647 17978813
38. Aldosterone antagonism in chronic kidney disease. Ponda MP, Hostetter TH, Clin J Am Soc Nephrol 2006 1 4 668 677 10.2215/CJN.00120106 17699271
39. Role of aldosterone in the remnant kidney model in the rat. Greene EL, Kren S, Hostetter TH, J Clin Invest 1996 98 4 1063 1068 10.1172/JCI118867 8770880 (Pubitemid 26293326)
40. Regression of existing glomerulosclerosis by inhibition of aldosterone. Aldigier JC, Kanjanbuch T, Ma LJ, Brown NJ, Fogo AB, J Am Soc Nephrol 2005 16 11 3306 3314 10.1681/ASN.2004090804 16192423 (Pubitemid 46187550)
41. Molecular mechanisms and therapeutic strategies of chronic renal injury: renoprotective effects of aldosterone blockade. Nishiyama A, Abe Y, J Pharmacol Sci 2006 100 1 9 16 10.1254/jphs.FMJ05003X3 16397374 (Pubitemid 43161608)
42. Possible contributions of reactive oxygen species and mitogen-activated protein kinase to renal injury in aldosterone/salt-induced hypertensive rats. Nishiyama A, Yao L, Nagai Y, Miyata K, Yoshizumi M, Kagami S, Kondo S, Kiyomoto H, Shokoji T, Kimura S, kohno M, Abe Y, Hypertension 2004 43 4 841 848 10.1161/01.HYP.0000118519.66430.22 14769808 (Pubitemid 38405598)
43. Adrenocortical hormone secretory response to chronic NH4Cl-induced metabolic acidosis. Schambelan M, Sebastian A, Katuna BA, Arteaga E, Am J Physiol 1987 252 4 Pt 1 454 460 3105328
44. Endothelin-induced increased aldosterone activity mediates augmented distal nephron acidification as a result of dietary protein. Khanna A, Simoni J, Wesson DE, J Am Soc Nephrol 2005 16 7 1929 1935 10.1681/ASN.2004121054 15872074 (Pubitemid 41716423)
45. Acid retention during kidney failure induces endothelin and aldosterone production which lead to progressive GFR decline, a situation ameliorated by alkali diet. Wesson DE, Simoni J, Kidney Int 2010 78 11 1128 1135 10.1038/ki.2010.348 20861823
46. Acid stress increases gene expression of proinflammatory cytokines in Madin-Darby canine kidney cells. Raj S, Scott DR, Nguyen T, Sachs G, Kraut JA, Am J Physiol Ren Physiol 2013 304 1 41 48 10.1152/ajprenal.00128.2012
47. Dietary acid load: a novel nutritional target in chronic kidney disease? Scialla JJ, Anderson CA, Adv Chronic Kidney Dis 2013 20 2 141 149 10.1053/j.ackd.2012.11.001 23439373
48. Influence of diet on acid-base balance. Remer T, Semin Dial 2000 13 4 221 226 10923348
49. Potential hominin plant foods in northern Tanzania: semi-arid savannas versus savanna chimpanzee sites. Copeland SR, J Hum Evol 2009 57 4 365 378 10.1016/j.jhevol.2009.06.007 19733386
50. Paleolithic nutrition: twenty-five years later. Konner M, Eaton SB, Nutr Clin Pract 2010 25 6 594 602 10.1177/0884533610385702 21139123
51. Estimation of the net acid load of the diet of ancestral preagricultural Homo sapiens and their hominid ancestors. Sebastian A, Frassetto LA, Sellmeyer DE, Merriam RL, Morris RC Jr, Am J Clin Nutr 2002 76 6 1308 1316 12450898 (Pubitemid 35416567)
52. Estimation of the diet-dependent net acid load in 229 worldwide historically studied hunter-gatherer societies. Strohle A, Hahn A, Sebastian A, Am J Clin Nutr 2010 91 2 406 412 10.3945/ajcn.2009.28637 20042527
53. Diet-dependent acid load, Paleolithic [corrected] nutrition, and evolutionary health promotion. Eaton SB, Konner MJ, Cordain L, Am J Clin Nutr 2010 91 2 295 297 10.3945/ajcn.2009.29058 20042522
54. Universality in intermediary metabolism. Smith E, Morowitz HJ, Proc Natl Acad Sci U S A 2004 101 36 13168 13173 10.1073/pnas.0404922101 15340153 (Pubitemid 39209637)
55. Paleolithic nutrition. A consideration of its nature and current implications. Eaton SB, Konner M, N Engl J Med 1985 312 5 283 289 10.1056/NEJM198501313120505 2981409 (Pubitemid 15199367)
56. Origins and evolution of the Western diet: health implications for the 21st century. Cordain L, Eaton SB, Sebastian A, Mann N, Lindeberg S, Watkins BA, O'Keefe JH, Brand-Miller J, Am J Clin Nutr 2005 81 2 341 354 15699220 (Pubitemid 43078368)
57. Dietary acid increases blood and renal cortical acid content in rats. Wesson DE, Am J Physiol 1998 274 1 Pt 2 97 103 9458828
58. Increased tissue acid mediates a progressive decline in the glomerular filtration rate of animals with reduced nephron mass. Wesson DE, Simoni J, Kidney Int 2009 75 9 929 935 10.1038/ki.2009.6 19190678
59. Acid retention accompanies reduced GFR in humans and increases plasma levels of endothelin and aldosterone. Wesson DE, Simoni J, Broglio K, Sheather S, Am J Physiol Ren physiol 2011 300 4 830 837 10.1152/ajprenal.00587.2010
60. Dietary Acid, Age, and Serum Bicarbonate Levels among Adults in the United States. Amodu A, Abramowitz MK, Clin J Am Soc Nephrol 2013 8 12 2034 2042 10.2215/CJN.03600413 24052219
61. Estimated net endogenous acid production and serum bicarbonate in African Americans with chronic kidney disease. Scialla JJ, Appel LJ, Astor BC, Miller ER 3rd, Beddhu S, Woodward M, Parekh RS, Anderson CA, Clin J Am Soc Nephrol 2011 6 7 1526 1532 10.2215/CJN.00150111 21700817
62. Net endogenous acid production is associated with a faster decline in GFR in African Americans. Scialla JJ, Appel LJ, Astor BC, Miller ER 3rd, Beddhu S, Woodward M, Parekh RS, Anderson CA, African American Study of Kidney D, Hypertension Study G, Kidney Int 2012 82 1 106 112 10.1038/ki.2012.82 22475819
63. Bicarbonate supplementation slows progression of CKD and improves nutritional status. de Brito-Ashurst I, Varagunam M, Raftery MJ, Yaqoob MM, J Am Soc Nephrol 2009 20 9 2075 2084 10.1681/ASN.2008111205 19608703
64. Amelioration of metabolic acidosis in patients with low GFR reduced kidney endothelin production and kidney injury, and better preserved GFR. Phisitkul S, Khanna A, Simoni J, Broglio K, Sheather S, Rajab MH, Wesson DE, Kidney Int 2010 77 7 617 623 10.1038/ki.2009.519 20072112
65. Daily oral sodium bicarbonate preserves glomerular filtration rate by slowing its decline in early hypertensive nephropathy. Mahajan A, Simoni J, Sheather SJ, Broglio KR, Rajab MH, Wesson DE, Kidney Int 2010 78 3 303 309 10.1038/ki.2010.129 20445497
66. Dietary acid reduction with fruits and vegetables or bicarbonate attenuates kidney injury in patients with a moderately reduced glomerular filtration rate due to hypertensive nephropathy. Goraya N, Simoni J, Jo C, Wesson DE, Kidney Int 2012 81 1 86 93 10.1038/ki.2011.313 21881553
67. A comparison of treating metabolic acidosis in CKD stage 4 hypertensive kidney disease with fruits and vegetables or sodium bicarbonate. Goraya N, Simoni J, Jo CH, Wesson DE, Clin J Am Soc Nephrol 2013 8 3 371 381 10.2215/CJN.02430312 23393104
68. Short- and long-term effects of alkali therapy in chronic kidney disease: a systematic review. Susantitaphong P, Sewaralthahab K, Balk EM, Jaber BL, Madias NE, Am J Nephrol 2012 35 6 540 547 10.1159/000339329 22653322
69. Correction of Metabolic Acidosis in End Stage Renal Disease. [clinicaltrials.gov/show/NCT01640119]
70. Akali Therapy in Chronic Kidney Disease. [clinicaltrials.gov/show/ NCT01452412]
71. Effect of oral sodium bicarbonate supplementation on progression of chronic kidney disease in patients with chronic metabolic acidosis: study protocol for a randomized controlled trial (SoBic-Study). Gaggl M, Cejka D, Plischke M, Heinze G, Fraunschiel M, Schmidt A, Horl WH, Sunder-Plassmann G, Trials 2013 14 1 196 10.1186/1745-6215-14-196 23826760